Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

4,300.00p
   
  • Change Today:
    -50.00p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 615
  • Market Cap: £224.45m

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

1 Day Chart (26-07-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 3.5% 0.0%
Div Cover 1.1 1.0
Op Mrgn 78.3% 80.0%
ROCE 83.0%  
Latest F'cast
P/E 27.1 25.1
PEG 3.0 7.2
Pr/Revenue 17.7 15.6
Pr/Book 18.8  
Latest F'cast
Revenue 9.4% 9.2%
PBT 9.2% 10.5%
EPS 9.0% 3.5%
DPS 20.6% 5.9%

Bioventix Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 9.29 6.97 114.04p 32.8 8.2 +4% 73.00p 2.0%
30-Jun-20 10.31 8.23 139.41p 29.8 1.4 +22% 88.00p 2.1%
30-Jun-21 10.93 8.12 129.22p 30.7 n/a -7% 105.00p 2.6%
30-Jun-22 11.72 9.28 147.32p 23.4 1.7 +14% 126.00p 3.7%
30-Jun-23 12.82 10.13 160.63p 24.0 2.7 +9% 152.00p 3.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Bioventix Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-24 14.00 11.20 166.20p 26.2 7.6 +4% 161.00p 0.0%
30-Jun-25 15.10 12.10 179.30p 24.3 3.1 +8% 172.00p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Bioventix Company Announcements

Director/PDMR Shareholding 30-Apr-2024 07:00 RNS
Holding(s) in Company 12-Apr-2024 11:05 RNS
Interim Results 25-Mar-2024 07:00 RNS

Bioventix ShareCast News

BioVentix revenue, earnings rise in first half 25-Mar-2024 ShareCast
Sunday share tips: Octopus Renewables Infrastruc... 19-Nov-2023 ShareCast
BioVentix revenue, profits improve in full-year ... 24-Oct-2022 ShareCast

Latest Bioventix Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,300.00p
Change Today -50.00p
% Change -1.15 %
52 Week High 5,060.00
52 Week Low 3,500.00
Volume 615
Shares Issued 5.22m
Market Cap £224.45m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
97.61% below the market average97.61% below the market average97.61% below the market average97.61% below the market average97.61% below the market average
96.08% below the sector average96.08% below the sector average96.08% below the sector average96.08% below the sector average96.08% below the sector average
Price Trend
46.53% above the market average46.53% above the market average46.53% above the market average46.53% above the market average46.53% above the market average
76.92% above the sector average76.92% above the sector average76.92% above the sector average76.92% above the sector average76.92% above the sector average
Income
12.64% above the market average12.64% above the market average12.64% above the market average12.64% above the market average12.64% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
27.25% below the market average27.25% below the market average27.25% below the market average27.25% below the market average27.25% below the market average
21.21% above the sector average21.21% above the sector average21.21% above the sector average21.21% above the sector average21.21% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 11-Apr-24 09-Nov-23
Paid 26-Apr-24 24-Nov-23
Amount 68.00p 90.00p

Trades for 26-Jul-2024

Time Volume / Share Price
14:02 5 @ 4,300.00p
13:36 300 @ 4,400.00p
13:11 45 @ 4,390.00p
11:48 2 @ 4,210.00p
10:32 220 @ 4,390.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page